Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 12, 2010
[Role of C-peptide in the pathogenesis of diabetic nephropathy]Valentina Martina, Anna Maestroni, Silvia Maestroni, et al.
Journal of Nephrology|December 6, 2007
Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathyGianpaolo Zerbini, Daniela Gabellini, Silvia Maestroni, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2003
Increased sodium-lithium countertransport activity: a cellular dysfunction common to essential hypertension and diabetic nephropathyGianpaolo Zerbini, Daniela Gabellini, Dora Ruggieri, et al.
Current Diabetes Reviews|January 29, 2008
Dysfunction of cellular transporters and predisposition to diabetic nephropathyGianpaolo Zerbini, Daniela Gabellini, Dora Ruggieri, et al.
European Journal of Endocrinology|March 15, 2005
C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathwayAnna Maestroni, Dora Ruggieri, Giacomo Dell'Antonio, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2006
Stem cells and the kidney: a new therapeutic tool?Gianpaolo Zerbini, Lorenzo Piemonti, Anna Maestroni, et al.
Diabetes|May 27, 2003
Alternative splicing of NHE-1 mediates Na-Li countertransport and associates with activity rateGianpaolo Zerbini, Anna Maestroni, Diego Breviario, et al.
Retina (Philadelphia, Pa.)|April 17, 2014
Endothelial progenitor cells and response to ranibizumab in age-related macular degenerationFabrizio Scotti, Anna Maestroni, Alessio Palini, et al.
Journal of Diabetes and Its Complications|August 23, 2005
Inhibition of MAP-kinase cascade normalizes the proliferation rate of fibroblasts from patients with Type 1 diabetes and nephropathyAnna Maestroni, Francesca Tentori, Giancarla Meregalli, et al.
Experimental Diabetes Research|May 9, 2012
The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatmentGemma Tremolada, Claudia Del Turco, Rosangela Lattanzio, et al.
Pageof 4